expects to drive sales through its focus on growth opportunities in Indonesia and the private market in Malaysia while awaiting for the extension of its logistics and distribution agreement with the Health Ministry.
The logistic and distribution agreement is targeted to be executed in the fourth quarter of 2022, the pharmaceutical company said in a filing with Bursa Malaysia yesterday.
대한민국 최근 뉴스, 대한민국 헤드 라인
Similar News:다른 뉴스 소스에서 수집한 이와 유사한 뉴스 기사를 읽을 수도 있습니다.
출처: staronline - 🏆 4. / 75 더 많은 것을 읽으십시오 »